Rational design of an NLRP3 inhibitor with superior efficacy and safety for gout therapy
Fields of Study & Subjects
Gout
Hyperuricemia
Uric Acid
Inflammasome and immune disorders
Hepatitis C virus research
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 305
- Pages
- 118578–118578
- Publication date
- 13 January 2026
- Language
- EN